Biotechnology / pharmaceutical consulting firm
| Year | Client | Period | Income | Expenses | Doc |
|---|---|---|---|---|---|
| 2013 | BIOCRYST PHARMACEUTICALS, INC. |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Termination (No Activity) |
— | — | |
| 2013 | BIOCRYST PHARMACEUTICALS, INC. |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Termination (No Activity) |
— | — | |
| 2013 | BIOCRYST PHARMACEUTICALS, INC. |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report (No Activity) |
— | — | |
| 2013 | BIOCRYST PHARMACEUTICALS, INC. |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$30,000 | — | |
| 2013 | BIOCRYST PHARMACEUTICALS, INC. |
2nd Quarter (Apr 1 - June 30) AMENDED |
— | — | |
| 2013 | BIOCRYST PHARMACEUTICALS, INC. |
2nd Quarter (Apr 1 - June 30) Registration |
— | — |
| Client | Filings | Total Income |
|---|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | 9 | $40,000 |
| Name | Disclosed Prior Position |
|---|---|
| DENA MINNING |